![Peter D. Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter D. Parker
Fundador en
LabCentral, Inc.
.
Perfil
Peter is a Venture Partner at Mission Bay Capital and Managing General Partner of BioInnovation Capital.
For nearly 20 years, Peter Parker was a General Partner at Ampersand Capital Partners, Wellesley MA, where he co-led the firm’s Life Sciences activities.
For the past several years, Peter has played a major role in the greater Boston/Cambridge life sciences start-up community.
At MassChallenge, he was the healthcare/life sciences ‘Champion’ for that Boston accelerator for five years.
He is a co-founder of BioInnovation Capital, Cambridge BioLabs and the BioLabs network, and is a member of several Angel investing groups.
Together with Johannes Fruehauf he has launched LabCentral, Inc., a major addition to the life sciences start-up ecosystem on the East coast.
From 2006–2010 he was President and CEO of Cequent Pharmaceuticals (sold to Marina Biotech).
He has served as a director of numerous companies including ACLARA Biosciences, Tomah Products, VITEX, Magellan Biosciences, Dynex, Castlewood Surgical and Pentose Pharmaceuticals and as Chairman of Alexis, NOVEX, CoPharma, Huntington Laboratories, Protein Ingredient Technologies, Cyclis Pharmaceuticals, Nanodyne, Panacos Pharmaceuticals, AC Tech, BioEssences and TekCel.
Prior to Ampersand, Peter spent fourteen years at AMAX, Inc. Peter Parker holds BS and MS degrees from Columbia University.
Cargos activos de Peter D. Parker
| Empresas | Cargo | Inicio |
|---|---|---|
BioInnovation Management LLC
 BioInnovation Management LLC Investment ManagersFinance BioInnovation Management invests in companies located in the United States. The firm focuses on health and biotechnology sectors. It provides financing for early stage capital requirements. | Fundador | 01/01/2009 |
Massachusetts Life Sciences Center
 Massachusetts Life Sciences Center Investment ManagersFinance Functions as a Pension/Retirement Fund | Director/Miembro de la Junta | 18/12/2014 |
LabCentral, Inc.
 LabCentral, Inc. Miscellaneous Commercial ServicesCommercial Services Provides grant making services for bio-tech companies | Fundador | 01/09/2012 |
Mediar Therapeutics, Inc.
 Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic | Director/Miembro de la Junta | - |
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital invests in companies located in the United States. The firm focuses on the biotechnology and life sciences sector. It participates in early stage capital transactions. Mission Bay Capital reorganized its operating segments on January 21,2020, by combining BioInnovation Management LLC and Mission Bay Capital Management Inc into a single segment called - Mission BioCapital. | Inversor de Capital Privado | - |
Nanodyne Labs LLC
 Nanodyne Labs LLC Electronic Equipment/InstrumentsElectronic Technology Develops wearable sensors with microfluidic technology and liquid graphene | Presidente | - |
AC Technology, Inc.
 AC Technology, Inc. Packaged SoftwareTechnology Services Provides information technology services & solutions | Presidente | - |
Two Lanterns Venture Partners LLC
 Two Lanterns Venture Partners LLC Investment ManagersFinance Two Lanterns Venture invests in companies located in the United States and Israel. The firm focuses on the software sector. It participates in pre-seed and seed stage capital requirements. | Consultor / Asesor | - |
Antiguos cargos conocidos de Peter D. Parker.
| Empresas | Cargo | Fin |
|---|---|---|
| ADHERA THERAPEUTICS, INC. | Presidente | 22/08/2012 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formación de Peter D. Parker.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
64
Relaciones de 1er grado
34
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 34 |
|---|---|
Amax, Inc.
 Amax, Inc. Other Metals/MineralsNon-Energy Minerals Manufactures and distributes value-added metal related products and produces oil and gas | Non-Energy Minerals |
ACLARA Biosciences, Inc.
 ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology Discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic and oncologic diseases | Health Technology |
Panacos Pharmaceuticals, Inc. /Old/
 Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Researches and develops next generation antiviral drugs for the treatment of HIV | Commercial Services |
Vitex Systems, Inc. | |
Cequent Pharmaceuticals, Inc.
 Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and pharmaceuticals | Health Technology |
Castlewood Surgical, Inc.
 Castlewood Surgical, Inc. BiotechnologyHealth Technology Provides medical devices and healthcare services | Health Technology |
Boston Heart Diagnostics Corp.
 Boston Heart Diagnostics Corp. Medical/Nursing ServicesHealth Services Provides cardiovascular disease clinical services | Health Services |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lonza Hopkinton, Inc.
 Lonza Hopkinton, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Tomah Products, Inc.
 Tomah Products, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures chemical surfactants | Process Industries |
Huntington Laboratories, Inc.
 Huntington Laboratories, Inc. Household/Personal CareConsumer Non-Durables Manufactures cleaning and sanitary products | Consumer Non-Durables |
Novex Corp.
 Novex Corp. Electronic ComponentsElectronic Technology Develops electrophoresis gels and related products | Electronic Technology |
Lenze AC Tech Corp
 Lenze AC Tech Corp Industrial MachineryProducer Manufacturing Develops motion control solutions | Producer Manufacturing |
Pentose Pharmaceuticals, Inc.
 Pentose Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel antiviral products | Health Technology |
Cyclis Pharmaceuticals, Inc.
 Cyclis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops small molecule drugs for the treatment of cancer | Health Technology |
TekCel, Inc.
 TekCel, Inc. Medical SpecialtiesHealth Technology Provides sample-management and assay automation systems for life science research | Health Technology |
Alexis Group LLC | |
Magellan Diagnostics, Inc.
 Magellan Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic laboratory products | Health Technology |
AC Technology, Inc.
AC Technology, Inc. Packaged SoftwareTechnology Services Provides information technology services & solutions | Technology Services |
Protient, Inc.
 Protient, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Manufactures and markets dairy proteins | Consumer Non-Durables |
Dynex Capital Corp.
 Dynex Capital Corp. Investment ManagersFinance Operates as a venture capital firm | Finance |
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital invests in companies located in the United States. The firm focuses on the biotechnology and life sciences sector. It participates in early stage capital transactions. Mission Bay Capital reorganized its operating segments on January 21,2020, by combining BioInnovation Management LLC and Mission Bay Capital Management Inc into a single segment called - Mission BioCapital. | Finance |
Massachusetts Life Sciences Center
Massachusetts Life Sciences Center Investment ManagersFinance Functions as a Pension/Retirement Fund | Finance |
Adhera Therapeutics, Inc.
 Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
Umicore Nanomaterials, Inc.
 Umicore Nanomaterials, Inc. Packaged SoftwareTechnology Services Develops materials technology | Technology Services |
Climax Performance Materials Corp. | |
ATS Labs, Inc.
 ATS Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Provides microbiology, virology and product chemistry testing services | Commercial Services |
BioInnovation Management LLC
BioInnovation Management LLC Investment ManagersFinance BioInnovation Management invests in companies located in the United States. The firm focuses on health and biotechnology sectors. It provides financing for early stage capital requirements. | Finance |
LabCentral, Inc.
LabCentral, Inc. Miscellaneous Commercial ServicesCommercial Services Provides grant making services for bio-tech companies | Commercial Services |
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic | Health Technology |
Two Lanterns Venture Partners LLC
Two Lanterns Venture Partners LLC Investment ManagersFinance Two Lanterns Venture invests in companies located in the United States and Israel. The firm focuses on the software sector. It participates in pre-seed and seed stage capital requirements. | Finance |
Cambridge Biolabs Ltd. | |
Nanodyne Labs LLC
Nanodyne Labs LLC Electronic Equipment/InstrumentsElectronic Technology Develops wearable sensors with microfluidic technology and liquid graphene | Electronic Technology |
- Bolsa de valores
- Insiders
- Peter D. Parker
